Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network

Blood Cancer J. 2022 Jun 24;12(6):94. doi: 10.1038/s41408-022-00692-8.
No abstract available

MeSH terms

  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / epidemiology
  • Leukemia, Myeloid*

Substances

  • Imatinib Mesylate